ASX Announcement 30 October 2026 Cleansing Notice The Board of Invex Therapeutics Limited (ASX: IXC) (“Invex” or “the Company”) hereby provides notice pursuant to section 708A(5)(e) of the Corporations Act 2001 (Cth) (Corporations Act), that The Company: 1. On 30 October 2026, the Company...
Section 708A Cleansing Notice
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Invex Therapeutics Ltd. has issued a cleansing notice regarding a recent share placement. The company issued shares to sophisticated and professional investors to raise funds without disclosure under certain regulations. This notice confirms compliance with relevant provisions of the Corporations Act and states there is no excluded information to disclose. An Appendix related to this share issue was also released on the same date.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Invex Therapeutics Ltd. on 6ix
Earlier from Invex Therapeutics
- Application for quotation of securities - IXC
- Quarterly Activities/Appendix 4C Cash Flow Report
- Proposed issue of securities - IXC
- Invex to Acquire Rekover Therapeutics
- Trading Halt
Later from Invex Therapeutics
All Invex Therapeutics news releasesFollow Invex Therapeutics into a list and get an email when it puts out news.
Follow Invex Therapeutics